MaxCyte, Inc. (MXCT) Revenue History
MaxCyte, Inc. (MXCT) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $33.89M |
| 2022-12-31 | $44.26M |
| 2023-12-31 | $41.29M |
| 2024-12-31 | $38.63M |
| 2025-12-31 | $33.03M |
How MXCT compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| ALEC | Alector Inc. | $21.05M |
| VERU | Veru Inc. | $16.89M |
These are five companies in the same sector as MXCT with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get MaxCyte, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("MXCT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MXCT | $1.32 | +0.00% | 3.80M |
| 3 | ||||
| 4 | ||||
| 5 |